BI
NVO

Binnacle Investments’s Novo Nordisk NVO Stock Holding History

Binnacle Investments’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$95K Buy
1,712
+522
+44% +$30.6K 0.06% 111
2025
Q2 		$82.1K Buy
1,190
+664
+126% +$45.2K 0.05% 110
2025
Q1 		$36.5K Buy
+526
New +$43.4K 0.03% 150

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Binnacle Investments's NVO Position: Q3 2025 in Review

Binnacle Investments increased its Novo Nordisk (NVO) stake by 44% in Q3 2025, buying an estimated $30.6K and bringing the position to 1,712 shares worth $95K. The position accounts for 0.06% of the portfolio, ranked #111.

Binnacle Investments first reported a position in NVO in Q1 2025 and has held it in 3 quarters since. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Binnacle Investments held 1,712 shares of Novo Nordisk worth $95K as of Q3 2025.
  • Binnacle Investments bought 522 Novo Nordisk shares in Q3 2025, an estimated $30.6K.
  • Novo Nordisk made up 0.06% of Binnacle Investments's portfolio in Q3 2025, its #111 holding.
  • Binnacle Investments first reported a position in Novo Nordisk in Q1 2025 and has held it in 3 quarters since.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Binnacle Investments's 13F filing for Q3 2025, filed 14 Nov 2025.